JENNISON ASSOCIATES LLC 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 4:11 pm Sale | 2026-03-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | JENNISON ASSOCIATES LLC | 4,980,770 4.000% | -1,777,236 (-26.30%) | Filing |
| 2026-01-30 4:21 pm Sale | 2025-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | JENNISON ASSOCIATES LLC | 6,758,006 5.500% | -5,496,113 (-44.85%) | Filing |
| 2025-10-06 5:46 pm Purchase | 2025-09-30 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | JENNISON ASSOCIATES LLC | 12,254,119 10.200% | 893,244 (+7.86%) | Filing |
| 2025-05-08 5:59 pm Sale | 2025-03-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | JENNISON ASSOCIATES LLC | 11,360,875 9.600% | -767,658 (-6.33%) | Filing |
| 2024-03-06 10:31 am Purchase | 2024-03-06 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | JENNISON ASSOCIATES LLC | 12,128,533 10.800% | 3,062,451 (+33.78%) | Filing |
| 2024-02-08 12:52 pm Purchase | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | JENNISON ASSOCIATES LLC | 9,066,082 9.600% | 9,066,082 (New Position) | Filing |